Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women

British Medical Journal

Volumn 307, Issue 6915, 1993, Pages 1318-1322

  Stensvold, Inger ^a   Tverdal, Aage ^a   Urdal, Petter ^b   Graff Iversen, Sidsel ^a  

^a National Health Screening Service   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MORTALITY; NORWAY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGE; MORTALITY; NORWAY; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 0027490520     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.307.6915.1318     Document Type: Article

References (23)

1. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 1980;302:1383-9.
2. Austin MA, Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidermiol 1989;129:249-59.
3. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein, and Coronary Disease. Triglyceride, high-density lipoprotein and coronary disease. JAMA 1993;269:505-10.
4. Carlson LA, Böttiger LE. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm prospective study. Acta Medica Scandinavica 1985;218:207-11.
5. Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rybo E. Triglycerides - main lipid risk factor for cardiovascular disease in women? Acta Medica Scandinavica 1985;217:481-9.
6. Tverdal A, Foss OP, Leren P, Holme I, Lund-Larsen PG, Bjartveit K. Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol 1989;129:458-65.
7. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Medica Scandinavia. Supplementum 1979;634:1-70.
8. Westlund K, Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3,751 men aged 40-49. Scand J Clin Lab Invest Suppl 1972;suppl 127:1-24.
9. Natvig H, Borchgrevnik CF, Dedichen J, Owren PA, Schictz E, Westlund K. A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66. Scand J Clin Lab Invest Suppl 1968;suppl 105:1-20.
10. World Health Organisation. International classification of diseases, injuries, and causes of death. Eighth revision. Oslo: Statistisk sentralbyrå, 1973.
11. World Health Organisation. International classification of diseases, ninth revision. Oslo: Statistisk sentralbyrå, 1986.
12. Dixon WJ, Brown MB, Engelman L, Jennrich RI. BMDP statistical software. Berkeley: University of California Press, 1990.
13. National Health Screening Service, Health Services of Finnmark, Sogn og Fjordane and Oppland counties, Ullevål Hospital, Central Laboratory, Oslo. The cardiovascular disease study in Norwegian counties. Results from second screening. Oslo: National Health Screening Service, 1988.
14. Freedman DS, Gruchow HW, Anderson AJ, Rimm AA, Barboriak JJ. Relation of triglyceride levels to coronary artery disease: the Milwaukee cardiovascular data registry. Am J Epidemiol 1988;127:1118-30.
15. Stensvold I, Urdal P, Thürmer H, Tverdal A, Lund-Larsen PG, Foss OP. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J 1992;13:1155-63.
16. Costongs GMPJ, Janson PCW, Bas BM. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem 1985;23:7-16.
17. Hamsten A. Coagulation factors and hyperlipidaemia. Current Opinion in Lipidology 1991;2:26-71.
18. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205.
19. Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses Lancet 1986;ii:592-5.
20. Gianturco SH, Bradley WA. Triglyceride-rich lipoproteins and their role in atherogenesis. Current Opinion in Lipidology 1991;2:324-8.
21. Kashyap ML. Clinical utility and methods for assessing triglyceride-rich lipoprotein metabolism. Current Opinion in Lipidology 1991;2:379-84.
22. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-607.
23. Fontbonne A. Insulin. A sex hormone for cardiovascular risk? Circulation 1991;84:1442-4.